Advertisement

Topics

Discovery Partners International Company Profile

12:04 EDT 25th June 2018 | BioPortfolio

Discovery Partners recently completed the sale of all of the stock of Discovery Partners’ operating subsidiaries and all of Discovery Partners’ material operating assets pursuant to a stock and asset purchase agreement with Galapagos NV. and Biofocus Inc.., a subsidiary of Galapagos NV. Discovery Partners’ only remaining material assets following that sale are its cash, cash equivalents and short-term investments, its listing on the NASDAQ Global Market and its merger agreement with Infinity Pharmaceuticals, Inc. The terms of the Infinity merger agreement and the stock and asset purchase agreement with Galapagos and Biofocus, and the remaining assets of Discovery Partners following the closing of the transactions described in such agreements are contained in Discovery Partners’ filings with the Securities and Exchange Commission and are available elsewhere on this website. View SEC filings.

Location

9640 Towne Centre Drive
San Diego
California
92121
United States of America

Contact

Phone: (858) 455-8600
Fax: (858) 546-3081


News Articles [883 Associated News Articles listed on BioPortfolio]

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery.  Based in Oxford, e-Therapeutics has the mission of reducing the ti...

International agreement that human-relevant research is needed to enhance drug discovery

(Humane Society International) Proceedings of a multistakeholder workshop co-organized by The Humane Society of the United States, Humane Society International and the National Institutes of Health un...

Galapagos: Onno van de Stolpe, CEO

Onno van de Stolpe talks to Fintan Walton, about Galapagos' current business model and overall strategic outlook. They discuss the integration of BioFocus following its acquisition by Galapagos in Nov...

Almac Discovery: Using “Deep, rich and good science” to find partners in oncology and inflammation

In this episode of PharmaTelevision News Review, filmed at BioTrinity 2012, Paul Larsmon talks to Robert Grundy, Director of Commercial Development and Licensing, Almac Discovery

Netwrix Partners with Concept Searching to Enrich Security Intelligence with Data Discovery and ...

The partners will work together to support market demand by introducing an advanced security solution that delivers more insight into sensitive data and improves risk Read more...

GSK signs R&D agreement with India-based CRO Syngene

Syngene International has signed a multiyear agreement with GSK through which the companies will focus on accelerating the discovery of new drug candidates using the CROâs discovery services platform...

Cullinan Oncology partners with MAB Discovery

Astellas Partners with Discovery Communications for its Global Branding Campaign

PubMed Articles [1385 Associated PubMed Articles listed on BioPortfolio]

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

Efficacy of Crizotinib Among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-small-cell Lung Cancer.

ROS1 rearrangement-positive non-small-cell lung cancer (NSCLC) can be treated effectively, with an anaplastic lymphoma kinase (ALK)/ROS1/mesenchymal-epithelial transition factor inhibitor such as criz...

Direct Access to Versatile Electrophiles via Catalytic Oxidative Cyanation of Alkenes.

Nucleophilic attack on carbon-based electrophiles is a central reactivity paradigm in chemistry and biology. The steric and electronic properties of the electrophile dictate its reactivity with differ...

What Does it Need to Improve Nutrition Quality? The Role of Public Partners.

Public partners play a key role when we want to improve nutrition quality. They will not succeed, when they try to achieve the goal alone or tend to dominate other players. In their responsibility for...

How Patient Partners Influence Quality Improvement Efforts.

There is growing acknowledgement that patients are key stakeholders in improving quality of medical care, yet a key barrier to integrating patients into quality improvement teams (QITs) as patient par...

Clinical Trials [1409 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Companies [3487 Associated Companies listed on BioPortfolio]

Discovery Partners International

Discovery Partners recently completed the sale of all of the stock of Discovery Partners’ operating subsidiaries and all of Discovery Partners’ material operating assets pursuant to a stock and as...

Discovery Partners

Discovery Partners has five operational centers of excellence dedicated to servicing the drug discovery market: (1) Discovery Instrumentation; develops, manufactures, and markets IRORI equipment and c...

Partners International

Partners International was a successful business consulting firm during the 1980's. After 1990, the company founder, Michael Jingozian, moved to Oregon to pursue other interests.

Disovery Partners International

Premier partner for drug discovery, offeringtarget characterizaton, lead generation, lead optimization, medicinal, combinatorial and analytical chemistry services, automated high throughput solid and ...

Medical Discovery Partners LLC

Medical Discovery Partners LLC focuses on the development of innovative medical diagnostics technologies. The company specializes in bringing medical diagnostic research concepts to reality, by conduc...

More Information about "Discovery Partners International" on BioPortfolio

We have published hundreds of Discovery Partners International news stories on BioPortfolio along with dozens of Discovery Partners International Clinical Trials and PubMed Articles about Discovery Partners International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Discovery Partners International Companies in our database. You can also find out about relevant Discovery Partners International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record